QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TOI

QT84The Oncology Institute, Inc.
NASDAQ·Healthcare·Medical - Care Facilities·USA
Latest market price
5.26
+0.01+0.19%
OverviewShort InterestFilings
TOIQT84The Oncology Institute, Inc.·NASDAQ
OverviewShort InterestFilings
5.26+0.19%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17
Snapshot
Index-P/E-EPS (ttm)
-0.35
Insider Own-
Shs Outstand99.98M
Perf Week2.53%
Market Cap524.91MForward P/E-EPS next Y-0.08Insider Trans0.61%Shs Float-Perf Month28.29%
Enterprise Value599.49MPEG-EPS next Q-0.07Inst Own-Short Float-Perf Quarter48.59%
Income-4251773.00P/S0.96EPS this Y57.14%Inst Trans-Short Ratio-Perf Half Y36.98%
Sales545.78MP/B-EPS next Y46.67%ROA-25.87%Short Interest-Perf YTD47.75%
Book/sh-0.16P/C-EPS next 5Y-ROE326.77%52W High5.58 -5.73%Perf Year124.79%
Cash/sh0.30P/FCF-EPS past 3/5Y-ROIC-33.84%52W Low2.02 160.40%Perf 3Y-
Dividend Est.-EV/EBITDA-20.51Sales past 3/5Y25.91% 21.75%Gross Margin14.82%Volatility4.46% 5.18%Perf 5Y-
Dividend TTM-EV/Sales1.10EPS Y/Y TTM49.30%Oper. Margin-5.99%ATR (14)0.35Perf 10Y-
Dividend Ex-Date-Quick Ratio1.17Sales Y/Y TTM38.93%Profit Margin-7.97%RSI (14)64.59Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.47EPS Q/Q88.24%SMA208.67%Beta1.83Target Price7.50
Payout0.00%Debt/Eq-6.44Sales Q/Q41.35%SMA5026.56%Rel Volume1.26Prev Close5.25
Employees825LT Debt/Eq-6.00EarningsAug 12SMA20047.42%Avg Volume1.70MPrice5.26
IPO DateJun 04, 2020Option/ShortYes / YesEPS/Sales Surpr.71.43% 3.52%Net Debt/EBITDA-2.55Volume2,143,793Change0.19%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-17-26ReiteratedNeedhamBuy$5.00 → $7.00
Jun-08-26ReiteratedBTIGBuy$8.00
Nov-25-25InitiatedNeedhamBuy$5.00
Nov-11-22ReiteratedGuggenheimBuy$6.00
Aug-15-22ReiteratedJefferiesBuy$10
Latest News
Jun-17-26
Jun-17-2606:17AM
Needham Maintains Buy on Oncology Institute, Raises Price Target to $7Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue546503393
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A465426339
Gross Profit827654
Selling, General and Administrative Excl. Other811060
Research and Development
000
Other Operating Expense337114
Operating Income-33-36-60
Interest Expense8117
Unusual Expense
———
Non-Operating Income (Expense)413-3
Net Income Before Taxes-44-61-65
Income Taxes000
Consolidated Net Income-44-61-65
Net Income From Continuing Operations-44-61-65
Net Income-44-61-65
EPS (Recurring)-0.35-0.54-0.71
EPS (Basic, Before Extraordinaries)-0.35-0.54-0.71
EPS (Diluted)-0.35-0.54-0.71
EBITDA-29-43-51
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio9.816.54—
Gross Margin15.0215.1113.74
Operating Margin-6.04-7.16-15.27
Net Margin-8.06-12.13-16.54
Shares Outstanding1,01892475
Market Capitalization5,3553,289—
Operating Lease Expense
———
Insider Trading Volume
$5.66$5.12$4.57$4.02$3.48● Close Price0.00M5.18M10.35M15.53M20.70MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Podnos YaleChief Medical OfficerJun 08 '26Sale5.3823,451126,094259,527Jun 09 12:00 AM
Chernett Jorey10% OwnerJun 04 '26Buy4.7512,00057,00010,579,858Jun 05 12:00 AM
Chernett Jorey10% OwnerMay 20 '26Buy4.0733,500136,34510,567,858May 21 12:00 AM
Chernett Jorey10% OwnerMay 19 '26Buy4.0835,000142,95010,534,358May 21 12:00 AM
Kaushal MohitDirectorApr 16 '26Sale3.5038,433134,535172,583Apr 16 12:00 AM
Kaushal MohitDirectorApr 14 '26Sale3.5057,286200,598211,016Apr 16 12:00 AM
Chernett Jorey10% OwnerApr 09 '26Buy3.1020,00062,00010,499,358Apr 13 12:00 AM
Chernett Jorey10% OwnerMar 27 '26Buy2.9627,42981,19010,479,358Mar 30 12:00 AM
Chernett Jorey10% OwnerMar 26 '26Buy3.1550,000157,50010,451,929Mar 27 12:00 AM
Chernett Jorey10% OwnerMar 24 '26Buy3.11125,000388,75010,401,929Mar 25 12:00 AM
Chernett Jorey10% OwnerMar 20 '26Buy3.3525,00083,75010,276,929Mar 23 12:00 AM
Chernett Jorey10% OwnerMar 17 '26Buy3.4275,000256,50010,251,929Mar 17 12:00 AM
Chernett Jorey10% OwnerMar 16 '26Buy3.2960,985200,64110,176,929Mar 17 12:00 AM
Chernett Jorey10% OwnerMar 13 '26Buy2.92263,000767,96010,115,944Mar 17 12:00 AM
Carter Robert RossChief Financial OfficerJan 02 '26Sale3.56247879235,122Jan 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR